Intralesional administration of interferon A for the management of severe haemangiomas

[1]  P. Lloret.  Tratamiento médico de los hemangiomas , 2004 .

[2]  P. Lloret.  [Medical treatment of haemangiomas]. , 2004, Anales del sistema sanitario de Navarra.

[3]  J. Calvo,et al.  Interferón-alfa y hemangiomas orbitarios infantiles , 2003 .

[4]  A. Clerico,et al.  Recombinant Interferon Alfa 2A in Hepatic Hemangiomatosis with Congestive Heart Failure: A Case Report , 2003, Pediatric hematology and oncology.

[5]  J. Peralta Calvo,et al.  [Interferon alpha and infantile orbital hemangioma]. , 2003, Archivos de la Sociedad Espanola de Oftalmologia.

[6]  D. Lindner.  Interferons as antiangiogenic agents , 2002, Current oncology reports.

[7]  J. Mulliken,et al.  Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2 cases. , 2002, Pediatrics.

[8]  R. Saouaf,et al.  Effective therapy of a vascular tumor of infancy with vincristine. , 2001, Journal of pediatric surgery.

[9]  H. Fledelius,et al.  Interferon-alfa treatment of facial infantile haemangiomas: with emphasis on the sight-threatening varieties. A clinical series. , 2001, Acta ophthalmologica Scandinavica.

[10]  P. López-Saura,et al.  Regression of Infancy Hemangiomas with Recombinant IFN-α2b , 2001 .

[11]  P. López-Saura,et al.  Regression of infancy hemangiomas with recombinant IFN-alpha 2b. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[12]  E. Yeong,et al.  Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. , 2000, Journal of pediatric surgery.

[13]  O. Enjolras,et al.  Efficacité et danger de l'interféron alpha dans le traitement des hémangiomes graves du nourrisson , 2000 .

[14]  J. Giniès,et al.  [Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants]. , 2000, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[15]  L. Carmant,et al.  Toxicity profile of interferon alfa-2b in children: A prospective evaluation. , 1999, The Journal of pediatrics.

[16]  F. Teixeira,et al.  Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas. , 1997, Archives of dermatology.

[17]  R. Silverman.  Hemangiomas and vascular malformations. , 1991, Pediatric clinics of North America.

[18]  T. Tracy,et al.  Complex hemangiomas of infants and children. Individualized management in 22 cases. , 1990, Archives of surgery.

[19]  E. Borden,et al.  Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. , 1987, Cancer research.

[20]  M. Riché,et al.  The Treatment of Capillary‐Venous Malformations Using a New Fibrosing Agent , 1983, Plastic and reconstructive surgery.

[21]  B. Zetter,et al.  Inhibition of cell motility by interferon. , 1980, Science.

[22]  S. Miller,et al.  COMPRESSION TREATMENT OF HEMANGIOMAS , 1976, Plastic and reconstructive surgery.

[23]  R. Goldwyn,et al.  CRYOSURGERY FOR LARGE HEMANGIOMAS IN ADULTS , 1969, Plastic and reconstructive surgery.